Beyond Fed-Batch: Choosing The Right Path To Process Intensification

Capacity constraints in traditional fed-batch manufacturing are pushing producers toward upstream intensification, yet a single technical strategy rarely fits every organization. Compare options across the upstream workflow, from seed train optimization and fed-batch variants (concentrated fed-batch, high-productivity harvest, high inoculation density) to steady-state and N-stage perfusion. Comparative case studies report a 5- to 10-fold increase in cell density and a 2- to 10-fold increase in titer per batch, and tie those gains to bioreactor space-time yield and the economics of expanding output within an existing footprint.

Watch the full webinar to see how the strategies compare.